250 related articles for article (PubMed ID: 18420440)
21. [Treatment of the esophago-gastric junction adenocarcinoma].
Bîrlă R; Losif C; Gîndea C; Hoară P; Constantinoiu S
Chirurgia (Bucur); 2008; 103(2):143-53. PubMed ID: 18457092
[TBL] [Abstract][Full Text] [Related]
22. [Radical nature and life expectancy in the surgical treatment of esophageal and cardial carcinoma].
Kunath U; Fischer P
Dtsch Med Wochenschr; 1984 Mar; 109(12):450-3. PubMed ID: 6705695
[TBL] [Abstract][Full Text] [Related]
23. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
[TBL] [Abstract][Full Text] [Related]
24. [Radiochemotherapy for oesophageal cancer: a locoregional failure history].
Créhange G; Maingon P; Bosset JF
Cancer Radiother; 2008 Nov; 12(6-7):640-8. PubMed ID: 18845466
[TBL] [Abstract][Full Text] [Related]
25. [Role of the pathologist in the processing of adenocarcinoma of the stomach, oesophagogastric junction and lower third of the oesophagus].
Svrcek M; Fléjou JF
Ann Pathol; 2011 Dec; 31(6):419-26. PubMed ID: 22172114
[TBL] [Abstract][Full Text] [Related]
26. Multidisciplinary approach to esophageal and gastric cancer.
Quiros RM; Bui CL
Surg Clin North Am; 2009 Feb; 89(1):79-96, viii. PubMed ID: 19186232
[TBL] [Abstract][Full Text] [Related]
27. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
28. The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data.
Fiorica F; Cartei F; Enea M; Licata A; Cabibbo G; Carau B; Liboni A; Ursino S; Cammà C
Cancer Treat Rev; 2007 Dec; 33(8):729-40. PubMed ID: 17935888
[TBL] [Abstract][Full Text] [Related]
29. A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia.
Liu JF; Jamieson GG; Wu TC; Zhu GJ; Drew PA
Ann Surg Oncol; 2009 May; 16(5):1397-402. PubMed ID: 19241108
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant treatment in upper gastrointestinal adenocarcinomas: new paradigms from old concepts?
Samalin E; Ychou M
Curr Opin Oncol; 2007 Jul; 19(4):384-9. PubMed ID: 17545805
[TBL] [Abstract][Full Text] [Related]
31. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
[TBL] [Abstract][Full Text] [Related]
32. [Oesophageal cancer: what's new during the last 10 years?].
Triboulet JP; Mariette C
Bull Cancer; 2008 Apr; 95(4):425-31. PubMed ID: 18495572
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis of and therapy for gastric cancer--work-flow].
Grundmann RT; Hölscher AH; Bembenek A; Bollschweiler E; Drognitz O; Feuerbach S; Gastinger I; Hermanek P; Hopt UT; Hünerbein M; Illerhaus G; Junginger T; Kraus M; Meining A; Merkel S; Meyer HJ; Mönig SP; Piso P; Roder J; Rödel C; Tannapfel A; Wittekind C; Woeste G
Zentralbl Chir; 2009 Aug; 134(4):362-74. PubMed ID: 19688686
[TBL] [Abstract][Full Text] [Related]
34. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
Ku GY; Ilson DH
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
[TBL] [Abstract][Full Text] [Related]
35. Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: a direct and adjusted indirect comparison meta-analysis.
Kumagai K; Rouvelas I; Tsai JA; Mariosa D; Lind PA; Lindblad M; Ye W; Lundell L; Schuhmacher C; Mauer M; Burmeister BH; Thomas JM; Stahl M; Nilsson M
Eur J Surg Oncol; 2015 Mar; 41(3):282-94. PubMed ID: 25491892
[TBL] [Abstract][Full Text] [Related]
36. Role of chemotherapy in the treatment of gastroesophageal cancers.
Hwang JJ
Oncology (Williston Park); 2007 Apr; 21(5):579-86; discussion 587, 591-2. PubMed ID: 17536343
[TBL] [Abstract][Full Text] [Related]
37. Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer.
Bystricky B; Okines AF; Cunningham D
Drugs; 2011 Mar; 71(5):541-55. PubMed ID: 21443280
[TBL] [Abstract][Full Text] [Related]
38. [Left thoracic approach in carcinoma of the esophagogastric junction. Technics and results].
Husemann B
Chirurg; 1980 Sep; 51(9):584-8. PubMed ID: 7006937
[TBL] [Abstract][Full Text] [Related]
39. The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction Cancer.
Cartwright E; Cunningham D
Curr Treat Options Oncol; 2017 Nov; 18(12):69. PubMed ID: 29143893
[TBL] [Abstract][Full Text] [Related]
40. Current state of treatment of carcinoma of the oesophagus and gastro-oesophageal junction. Clinical review.
Lundell L; Olbe L
Acta Chir Scand; 1990 Mar; 156(3):193-202. PubMed ID: 2186586
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
